Tabula Rasa HealthCare Inc (TRHC) CEO Calvin H. Knowlton Sells 8,000 Shares

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) CEO Calvin H. Knowlton sold 8,000 shares of the firm’s stock in a transaction dated Thursday, February 7th. The shares were sold at an average price of $52.73, for a total value of $421,840.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Shares of TRHC opened at $55.53 on Wednesday. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.49 and a quick ratio of 0.46. The stock has a market capitalization of $1.10 billion, a PE ratio of -1,388.25, a P/E/G ratio of 3.35 and a beta of 1.79. Tabula Rasa HealthCare Inc has a 1 year low of $28.55 and a 1 year high of $91.16.

A number of brokerages recently commented on TRHC. Cantor Fitzgerald restated a “buy” rating and set a $99.00 target price on shares of Tabula Rasa HealthCare in a report on Tuesday, November 6th. Zacks Investment Research upgraded Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a report on Thursday, December 6th. Piper Jaffray Companies restated an “overweight” rating and set a $80.00 target price on shares of Tabula Rasa HealthCare in a report on Thursday, December 6th. BidaskClub cut Tabula Rasa HealthCare from a “sell” rating to a “strong sell” rating in a report on Saturday. Finally, Chardan Capital raised their target price on Tabula Rasa HealthCare from $77.00 to $91.00 and gave the company a “buy” rating in a report on Wednesday, November 7th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company’s stock. Tabula Rasa HealthCare presently has a consensus rating of “Buy” and a consensus price target of $82.27.

Institutional investors and hedge funds have recently made changes to their positions in the company. First Mercantile Trust Co. purchased a new position in shares of Tabula Rasa HealthCare in the 4th quarter valued at about $39,000. TCI Wealth Advisors Inc. boosted its stake in shares of Tabula Rasa HealthCare by 1,600.0% in the 4th quarter. TCI Wealth Advisors Inc. now owns 850 shares of the company’s stock valued at $54,000 after buying an additional 800 shares during the period. Quantamental Technologies LLC purchased a new position in shares of Tabula Rasa HealthCare in the 4th quarter valued at about $64,000. Oppenheimer Asset Management Inc. purchased a new position in shares of Tabula Rasa HealthCare in the 4th quarter valued at about $135,000. Finally, LS Investment Advisors LLC boosted its stake in shares of Tabula Rasa HealthCare by 19.9% in the 4th quarter. LS Investment Advisors LLC now owns 2,813 shares of the company’s stock valued at $179,000 after buying an additional 466 shares during the period. Institutional investors and hedge funds own 79.23% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally published by Markets Daily and is owned by of Markets Daily. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.themarketsdaily.com/2019/02/13/tabula-rasa-healthcare-inc-trhc-ceo-calvin-h-knowlton-sells-8000-shares-2.html.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Further Reading: What is the Consumer Price Index (CPI)?

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply